A Safety and Tolerability Study of ABT-126 in Elderly

A Multiple Dose Study of Safety, Tolerability and Pharmacokinetics of ABT-126 in Elderly Subjects

The objectives of this study are to assess the safety, tolerability and pharmacokinetics of ABT-126 in elderly subjects.

Inclusion Criteria:

• Healthy male or female subjects 65 years or greater.
• Has a MMSE score of 27 or higher.

Exclusion Criteria:

• History of dementia including by not limited to Alzheimer's disease, Parkinson's disease and mult-infarct dementia.
• History of any significant neurological disease.
• Has an estimated creatinine clearance < 30 mL/min